IL12RB1 Gene Atypical Mycobacterial Infection Genetic Test
Components
Test Name: IL12RB1 Gene Atypical Mycobacterial Infection Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for IL12RB1 Gene Atypical Mycobacterial Infection NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IL12RB1 Gene Atypical Mycobacterial Infection NGS Genetic DNA Test gene IL12RB1
Test Details
The IL12RB1 gene is responsible for encoding the interleukin-12 receptor beta-1 protein, which is involved in the immune system response to infections. Mutations in this gene can lead to a rare primary immunodeficiency disorder called IL12RB1 deficiency.
IL12RB1 deficiency is characterized by increased susceptibility to atypical mycobacterial infections, also known as non-tuberculous mycobacterial (NTM) infections. NTM infections are caused by various species of mycobacteria that are not the causative agents of tuberculosis or leprosy. These infections typically affect the lungs, but can also involve other organs such as the skin, lymph nodes, and bones.
Next-generation sequencing (NGS) genetic testing can be used to identify mutations in the IL12RB1 gene that may be responsible for IL12RB1 deficiency. NGS allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of an individual’s genetic makeup. This type of testing can help diagnose IL12RB1 deficiency and guide appropriate treatment strategies.
Treatment for IL12RB1 deficiency and associated atypical mycobacterial infections often involves antimicrobial therapy to control the infection. In some cases, bone marrow transplantation may be considered as a curative treatment option.
Genetic testing can help identify individuals at risk for IL12RB1 deficiency and guide appropriate management strategies to improve outcomes.
| Test Name | IL12RB1 Gene Atypical Mycobacterial infection Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for IL12RB1 Gene Atypical Mycobacterial infection NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IL12RB1 Gene Atypical Mycobacterial infection NGS Genetic DNA Test gene IL12RB1 |
| Test Details |
The IL12RB1 gene is responsible for encoding the interleukin-12 receptor beta-1 protein, which is involved in the immune system response to infections. Mutations in this gene can lead to a rare primary immunodeficiency disorder called IL12RB1 deficiency. IL12RB1 deficiency is characterized by increased susceptibility to atypical mycobacterial infections, also known as non-tuberculous mycobacterial (NTM) infections. NTM infections are caused by various species of mycobacteria that are not the causative agents of tuberculosis or leprosy. These infections typically affect the lungs, but can also involve other organs such as the skin, lymph nodes, and bones. Next-generation sequencing (NGS) genetic testing can be used to identify mutations in the IL12RB1 gene that may be responsible for IL12RB1 deficiency. NGS allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of an individual’s genetic makeup. This type of testing can help diagnose IL12RB1 deficiency and guide appropriate treatment strategies. Treatment for IL12RB1 deficiency and associated atypical mycobacterial infections often involves antimicrobial therapy to control the infection. In some cases, bone marrow transplantation may be considered as a curative treatment option. Genetic testing can help identify individuals at risk for IL12RB1 deficiency and guide appropriate management strategies to improve outcomes. |
